Related references
Note: Only part of the references are listed.Reaction-driven de novo design, synthesis and testing of potential type II kinase inhibitors
Gisbert Schneider et al.
FUTURE MEDICINAL CHEMISTRY (2011)
In Silico Characterization of Ligand Binding Modes in the Human Histamine H4 Receptor and their Impact on Receptor Activation
Tim Werner et al.
CHEMBIOCHEM (2010)
From Machine Learning to Natural Product Derivatives that Selectively Activate Transcription Factor PPARγ
Matthias Rupp et al.
CHEMMEDCHEM (2010)
De novo design: balancing novelty and confined chemical space
Peter S. Kutchukian et al.
EXPERT OPINION ON DRUG DISCOVERY (2010)
Design, Synthesis, and Biological Evaluation of a Novel Class of γ-Secretase Modulators with PPARγ Activity
Martina Hieke et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Bioisosteric Replacement and Scaffold Hopping in Lead Generation and Optimization
Sarah R. Langdon et al.
MOLECULAR INFORMATICS (2010)
Alzheimer's disease: strategies for disease modification
Martin Citron
NATURE REVIEWS DRUG DISCOVERY (2010)
Exploring the chemical space of gamma-secretase modulators
Heiko Zettl et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
High Constitutive Activity and a G-Protein-Independent High-Affinity State of the Human Histamine H4-Receptor
Erich H. Schneider et al.
BIOCHEMISTRY (2009)
2,4-Diaminopyrimidines as histamine H4 receptor ligands-Scaffold optimization and pharmacological characterization
Kerstin Sander et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics
Y. von Coburg et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Homology Model Adjustment and Ligand Screening with a Pseudoreceptor of the Human Histamine H4 Receptor
Yusuf Tanrikulu et al.
CHEMMEDCHEM (2009)
Histamine H-3 and H-4 receptors as novel drug targets
Ekaterini Tiligada et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
FOG: Fragment Optimized Growth Algorithm for the de Novo Generation of Molecules occupying Druglike Chemical Space
Peter S. Kutchukian et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Reaction-MQL: Line Notation for Functional Transformation
Felix H. Reisen et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Concept of combinatorial De novo design of drug-like molecules by particle swarm optimization
Markus Hartenfeller et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2008)
Fragment based design of new H4 receptor-ligands with anti-inflammatory properties in vivo
Rogier A. Smits et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Kernel approach to molecular similarity based con iterative graph similarity
Matthias Rupp et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)
Flux (2): Comparison of molecular mutation and crossover operators for ligand-based de novo design
Uli Fechner et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)
Identification of 2-arylbenzimidazoles as potent human histamine H4 receptor ligands
Alice Lee-Dutra et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Molecular complexity analysis of de novo designed ligands
Krisztina Boda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Flux (1): A virtual synthesis scheme for fragment-based de novo design
U Fechner et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2006)
Recent developments of the Chemistry Development Kit (CDK) - An open-source Java library for chemo- and bioinformatics
C Steinbeck et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Computer-based de novo design of drug-like molecules
G Schneider et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Aβ42 production
T Kukar et al.
NATURE MEDICINE (2005)
In-depth study of tripeptide-based α-ketoheterocycles as inhibitors of thrombin.: Effective utilization of the S1′ subsite and its implications to structure-based drug design
MJ Costanzo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
ZINC - A free database of commercially available compounds for virtual screening
JJ Irwin et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2005)
A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties
RL Thurmond et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Trypsin cleaves exclusively C-terminal to arginine and lysine residues
JV Olsen et al.
MOLECULAR & CELLULAR PROTEOMICS (2004)
SYNOPSIS: SYNthesize and OPtimize system in silico
HM Vinkers et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Novel thrombin inhibitors incorporating non-basic partially saturated heterobicyclic P1-arginine mimetics
L Peterlin-Masic et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
The Chemistry Development Kit (CDK): An open-source Java library for chemo- and bioinformatics
C Steinbeck et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2003)
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
S Weggen et al.
NATURE (2001)
De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks
G Schneider et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2000)
Share Paper
